2021-01-08,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021-01-04,"Mirum Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021"
2020-12-30,"What Kind Of Shareholders Own Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)?"
2020-12-22,Mirum Pharmaceuticals (MIRM) in Focus: Stock Moves 5.9% Higher
2020-12-14,Mirum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2020-12-14,Mirum Pharmaceuticals Announces Commencement of Public Offering of Common Stock
2020-12-10,Is MIRM A Good Stock To Buy Now?
2020-12-10,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-12-09,Mirum Pharmaceuticals and Oberland Capital Announce Up to $210 Million Funding Arrangement
2020-12-07,Mirum Pharmaceuticals Announces Virtual Investor Day 2020
2020-11-30,Mirum Pharmaceuticals Announces European Medicines Agency Validation of the Marketing Authorization Application for Maralixibat in Patients with PFIC2
2020-11-23,Mirum Pharmaceuticals to Present at Upcoming Investor Conferences
2020-11-15,Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with Maralixibat
2020-11-13,Mirum Pharmaceuticals Presents New Data From Its Maralixibat and Volixibat Clinical Studies at AASLD Annual Meeting
2020-11-12,"Mirum Pharmaceuticals Provides Third Quarter 2020 Financial Results and Business Update, and Announces Virtual Investor Day"
2020-11-10,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-11-05,Mirum Pharmaceuticals Broadens Expanded Access Program for Maralixibat in Alagille Syndrome to Europe and Australia
2020-11-02,Mirum Pharmaceuticals Announces New Data Being Presented in Late-Breaker Oral and Poster Presentations at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
2020-10-26,Mirum Pharmaceuticals to Present Maralixibat Data and Host Symposium at the NASPGHAN Annual Meeting 2020
2020-10-15,Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States
2020-10-15,Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States
2020-10-14,Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels
2020-10-13,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-11,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-09-11,Mirum Pharmaceuticals to Present at Investor Conferences in September
2020-09-01,Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome and Launches Expanded Access Program
2020-08-29,Mirum Pharmaceuticals Presents Maralixibat Five-Year Transplant-Free Survival Data for Patients With PFIC2 at Digital International Liver Congress 2020
2020-08-11,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-08-11,We're Hopeful That Mirum Pharmaceuticals (NASDAQ:MIRM) Will Use Its Cash Wisely
2020-08-11,Companies Like Mirum Pharmaceuticals (NASDAQ:MIRM) Are In A Position To Invest In Growth
2020-08-07,Mirum Pharmaceuticals to Present at the Canaccord Genuity 40th Annual Growth Conference
2020-08-06,Mirum Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Clinical Program Updates
2020-07-10,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-22,"Hedge Funds Are Nibbling On Mirum Pharmaceuticals, Inc. (MIRM)"
2020-06-11,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-06-02,Mirums Maralixibat Demonstrates Transplant-Free Survival for Pediatric Patients with Progressive Familial Intrahepatic Cholestasis
2020-05-29,Mirum Pharmaceuticals to Present at the Jefferies 2020 Healthcare Conference
2020-05-11,Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-05-07,Mirum Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Updates
2020-04-28,Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer
2020-03-12,Mirum Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
2020-02-18,Mirum Pharmaceuticals to Participate at Four Upcoming Conferences
2020-01-16,Frazier Healthcare Partners Closes Oversubscribed $617 Million Life Sciences Fund
2020-01-14,Mirum Pharmaceuticals Promotes Ian Clements to Chief Financial Officer
2020-01-08,Mirum Pharmaceuticals Announces Pricing of Public Offering
2019-12-24,"Is Mirum Pharmaceuticals, Inc. (MIRM) A Good Stock To Buy?"
2019-12-17,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO"
2019-12-16,Mirum Pharmaceuticals Completes Successful Pre-NDA Meeting with FDA for Maralixibat
2019-12-13,Mirum Pharmaceuticals to Provide Regulatory Update in Upcoming Conference Call and Webcast
2019-11-25,Mirum Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference
2019-11-25,Mirum Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference
2019-11-08,Mirum Pharmaceuticals Presents Data Demonstrating Long-term Durability of Treatment Effect of Maralixibat in Children With Cholestatic Liver Diseases
2019-11-06,Mirum Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
2019-10-28,Mirum Pharmaceuticals Announces Appointment of Ed Tucker as Chief Medical Officer
2019-10-28,Mirum Pharmaceuticals Announces Breakthrough Therapy Designation for Maralixibat for the Treatment of Pruritus Associated with Alagille Syndrome
2019-10-21,Durability of Treatment Effect of Mirum Pharmaceuticals Maralixibat for Children With Alagille Syndrome Featured in Late Breaking Session at the Liver Meeting 2019
2019-10-01,Mirum Pharmaceuticals to Present New Data at The Liver Meeting 2019
2019-09-26,Company Profile for Mirum Pharmaceuticals
2019-09-26,Mirum Pharmaceuticals to Present at Cantor 2019 Global Healthcare Conference
2019-08-28,Mirum Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
2019-08-12,"Mirum Pharma's Lead Asset Has $450M Sales Opportunity, Raymond James Says In Bullish Initiation"
2019-07-17,Mirum Pharmaceuticals Announces Pricing of Initial Public Offering
2019-07-15,"IPO Outlook For The Week: Biotechs, Financial Advisers, Medical Services And The Twitch Of China"
2019-07-12,Mirum Pharmaceuticals IPO: What You Need To Know
